Heart failure (HF) complicating myocardial infarction (MI) is common and may be present at
admission or develop during the hospitalization. Among patients with MI, there is a strong …

Background—Heart failure (HF) is an important predictor of poor outcome after acute
myocardial infarction (AMI). However, limited data exist about the clinical significance of HF …

Despite significant advances in its treatment, acute myocardial infarction (AMI) remains an
important cause of heart failure (HF). Contemporary data remain lacking, however …

Aims To investigate the association between long-term β-blocker therapy and clinical
outcomes in patients without heart failure (HF) after acute myocardial infarction (AMI) …

Objectives: To characterize the presentation and outcome of patients with heart failure (HF)
after myocardial infarction (MI) according to left ventricular ejection fraction (LVEF) and test …

Background: For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-
blockers are associated with reduced mortality. Objectives: The goal of this study was to …

Objectives: The aim of this study was to examine temporal trends in the incidence and
outcomes of heart failure (HF) complicating acute myocardial infarction (AMI) in a large …

Despite recent improvements in the management of congestive heart failure, the prognosis
of many patients with this condition remains poor. The level of neurohormonal activation …

In most patients with heart failure due to left ventricular systolic dysfunction, the underlying
cause is coronary heart disease. To reduce progression to heart failure in a patient with …

Background The occurrence of heart failure associated with an acute myocardial infarction
has a strong adverse effect on long-term morbidity and mortality. The prediction and …